These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fetal thoracoamniotic shunting for large macrocystic congenital cystic adenomatoid malformations of the lung. Schrey S; Kelly EN; Langer JC; Davies GA; Windrim R; Seaward PG; Ryan G Ultrasound Obstet Gynecol; 2012 May; 39(5):515-20. PubMed ID: 22223532 [TBL] [Abstract][Full Text] [Related]
5. [FETAL THERAPY: INTRAUTERINE THORACO-AMNIOTIC SHUNTING IN MACROCYSTIC TYPE CYSTIC ADENOMATOID MALFORMATION OF THE LUNG: REVIEW OF THE LITERATURE AND CASE REPORT]. Chaveeva P; Stratieva V; Shivachev H; Aktash S; Panova M; Shterev A Akush Ginekol (Sofiia); 2016; 55 Suppl 1 Pt 2():15-9. PubMed ID: 27509663 [TBL] [Abstract][Full Text] [Related]
6. Successful intrauterine therapy for congenital cystic adenomatoid malformation of the lung. A case report. Isnard M; Kohler A; Kohler M; Vayssière C; Favre R Fetal Diagn Ther; 2007; 22(5):325-9. PubMed ID: 17556817 [TBL] [Abstract][Full Text] [Related]
7. Thoracoamniotic Shunts in Macrocystic Lung Lesions: Case Series and Review of the Literature. Litwińska M; Litwińska E; Janiak K; Piaseczna-Piotrowska A; Gulczyńska E; Szaflik K Fetal Diagn Ther; 2017; 41(3):179-183. PubMed ID: 27489957 [TBL] [Abstract][Full Text] [Related]
8. The prenatal ultrasonic character and postnatal follow-up of 227 microcystic and macrocystic congenital cystic adenomatoid malformations. Chen Y; Zhao B; Xi F; Wang Y; Yang M; Luo Q J Obstet Gynaecol; 2021 May; 41(4):562-568. PubMed ID: 32851894 [TBL] [Abstract][Full Text] [Related]
9. Congenital adenomatoid malformation of the lung: when is active fetal therapy indicated? Dommergues M; Louis-Sylvestre C; Mandelbrot L; Aubry MC; Révillon Y; Jarreau PH; Dumez Y Am J Obstet Gynecol; 1997 Oct; 177(4):953-8. PubMed ID: 9369851 [TBL] [Abstract][Full Text] [Related]
10. [Fetal therapy--evaluation of intrauterine therapy in congenital cystic adenomatoid malformation of the lung (CCAM)]. Szaflik K; Litwińska M; Oszukowski P; Piaseczna-Piotrowska A; Litwińska E; Krzeszowski W; Gulczyńska E; Maroszyńkas I; Janiak K Ginekol Pol; 2015 Jan; 86(1):8-15. PubMed ID: 25775869 [TBL] [Abstract][Full Text] [Related]
11. Effect of maternal betamethasone administration on prenatal congenital cystic adenomatoid malformation growth and fetal survival. Peranteau WH; Wilson RD; Liechty KW; Johnson MP; Bebbington MW; Hedrick HL; Flake AW; Adzick NS Fetal Diagn Ther; 2007; 22(5):365-71. PubMed ID: 17556826 [TBL] [Abstract][Full Text] [Related]
13. To shunt or not to shunt a pulmonary adenomatoid cystic malformation after 33 weeks of gestation: a case report. Ruano R; Fettback PB; Ribeiro VL; Silva MM; Maksoud JG; Zugaib M Sao Paulo Med J; 2008 Jul; 126(4):239-41. PubMed ID: 18853037 [TBL] [Abstract][Full Text] [Related]
14. Residual congenital cystic adenomatoid malformation and thoracic scar deformation after fetal surgery: a case report. Phaloprakarn C; Pott Bärtsch EM; Harrison MR J Pediatr Surg; 2006 Feb; 41(2):e11-4. PubMed ID: 16481230 [TBL] [Abstract][Full Text] [Related]